Global Gynecology Partnering Report 2020: Access Deals Signed Between the World’s Leading Pharmaceutical and Biotechnology Companies Since 2010 -…

DUBLIN, Dec. 23, 2020 /PRNewswire/ -- The "Global Gynecology Partnering 2010-2020: Deal Trends, Players and Financials" report has been added to ResearchAndMarkets.com's offering.

Global Gynecology Partnering 2010-2020: Deal trends, players and financials provides the full collection of Gynecology disease deals signed between the world's pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Gynecology disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Gynecology deals.

The report presents financial deal terms values for Gynecology deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Gynecology partnering deals signed and announced since 2010. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

The report also includes numerous tables and figures that illustrate the trends and activities in Gynecology partnering and dealmaking since 2010.

The report includes deals for the following indications: Adenomyosis, Cervical Intraepithelial Neoplasia (CIN), Endometriosis, Fibroids, Human papillomavirus (HPV), Infertility, Menopause, Ovarian failure, Pelvic inflammatory disease, Polycystic ovary syndrome, Pre-menstrual syndrome, Prolapse, Amenorrhea, Dysmenorrhea, Pelvic pai, Vaginitis, plus other gynecological indications.

In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Gynecology technologies and products.

Global Gynecology Partnering 2010 to 2020 includes:

Available deals and contracts are listed by:

Key Topics Covered:

Executive Summary

Chapter 1 Introduction

Chapter 2 Trends in Gynecology dealmaking2.1. Introduction2.2. Gynecology partnering over the years2.3. Gynecology partnering by deal type2.4. Gynecology partnering by industry sector2.5. Gynecology partnering by stage of development2.6. Gynecology partnering by technology type2.7. Gynecology partnering by therapeutic indication

Chapter 3 Financial deal terms for Gynecology partnering3.1. Introduction3.2. Disclosed financials terms for Gynecology partnering3.3. Gynecology partnering headline values3.4. Gynecology deal upfront payments3.5. Gynecology deal milestone payments3.6. Gynecology royalty rates

Chapter 4 Leading Gynecology deals and dealmakers4.1. Introduction4.2. Most active in Gynecology partnering4.3. List of most active dealmakers in Gynecology4.4. Top Gynecology deals by value

Chapter 5 Gynecology contract document directory5.1. Introduction5.2. Gynecology partnering deals where contract document available

Chapter 6 Gynecology dealmaking by therapeutic target6.1. Introduction6.2. Deals by Gynecology therapeutic target

AppendicesAppendix 1 Directory of Gynecology deals by company A-Z 2010 to 2020Appendix 2 Directory of Gynecology deals by deal type 2010 to 2020Appendix 3 Directory of Gynecology deals by stage of development 2010 to 2020Appendix 4 Directory of Gynecology deals by technology type 2010 to 2020

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/9ex5qc

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets Laura Wood, Senior Manager [emailprotected]

For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

http://www.researchandmarkets.com

Read more:
Global Gynecology Partnering Report 2020: Access Deals Signed Between the World's Leading Pharmaceutical and Biotechnology Companies Since 2010 -...